FinancialContent is the trusted provider of stock market information to the media industry.
January 29, 2010 at 07:43 AM EST
Coronary Stents - Global Market Trends

NEW YORK, Jan. 29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Coronary Stents - Global Market Trends

http://www.reportlinker.com/p0164222/Coronary-Stents---Global-Market-Trends.html

Aging population, enhanced availability of sophisticated stents, rising patient affluence and affordability, and growing awareness are factors propelling growth of coronary stents. Advances in technology and novel formulations from new market entrants, have significantly contributed to market growth. Thorny regulatory barriers in certain countries such as Japan continue to plague the industry leading to higher product prices. Improvement in cardiac care resulting in greater number of positive outcomes of coronary stenting will also lead to market expansion.

These and other market data and trends are presented in "Coronary Stents: Global Market Trends" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

CORONARY STENTS BMR-1022

CONTENTS

1. METHODOLOGY 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Quantitative Techniques & Reporting Level 3

2. GLOBAL MARKET OVERVIEW 4

Drug Eluting Stents Steal the Show 4

Cypher and Taxus Dominate Global DES Market 4

A 10-Year Outlook for the Coronary Stents Industry 5

3. MARKET TRENDS AND ISSUES 6

Drug Eluting Stent System - Safety Concerns 6

Drug Eluting Stent Market to Bounce Back 6

Coronary Stents Market Challenged by Drug Therapy 7

Restenosis - the Real Growth Driver 7

Small Vessels - A Major Cause of Restenosis 7

Aging Population Propels Coronary Stent Market 8

Cell Transplantation - A Major Threat to Coronary Stents 8

Next Generation Stents - A Boon for Treating Coronary Diseases 8

Direct Stenting Systems Spur Growth 9

Drug Choice Impacts Market Entry 9

Price and Quality Concerns Dog Supplies and Demand for DES 9

DES' Introduction Skyrockets Coronary Stent Prices 10

Legal Challenges Right Behind 10

New Competition Puts Tabs on Coronary Stenting 10

4. COMPETITIVE ANALYSIS 10

5. PRODUCT FACTS 12

Bare Metal Stents 12

Major Bare Metal Stents by Company 12

Drug Eluting Stents 12

Major Drug-Eluting Stents by Company 13

A Peek into Regulatory Approvals for Coronary Stents 13

6. RESEARCH AND DEVELOPMENT 14

Extensive R&D Underway in Global Drug- Eluting Stents Market 14

At the Labs 14

Other Products Under Trials - A Recent Past Perspective 15

OMT Developing R-stent 15

Reva Developing Stainless Steel Bare- Metal Stent 15

D & P Corp Developing Bovine Pericardium - Covered Stent 15

Advanced Bio Synthesizing Porous Drug - Eluting Stents 15

Lombard Medical Developing PEP Coatings 16

Shiga Develops Biodegradable Drug- Eluting Stent 16

7. CORPORATE DEVELOPMENTS 16

Medtronic Receives the US FDA Approval to Use Endeavor® Stent 16

Medtronic Inc. Receives Approval for its Drug- Eluting Stent,

"Endeavor" In Canada 16

Boston Scientific to Market TAXUS® Liberte® Stent System in

Canada 17

Abbott Applies for Approval of XIENCE™ V in Japan 17

Medinol Achieves CE Mark Approval for Presillion™ Cobalt

Chromium Coronary Stent System 17

Iberhospitex Receives Spanish Approval to Sell Palau Pharma's

"Active" Coronary Stent 18

Clearstream's Intrepide Drug Eluting Stent of Clearstream

Receives CE mark approval 18

Terumo Introduces Its Drug-Eluting Stent in Germany and Marks

Its European Entry 18

Tryton Medical's Side-Branch Stent Achieves CE Mark Approval 18

CV Therapeutics Offers its Stent Coating Technology to

Medlogics Device Corporation 18

Abbott's 2.25mm-Sized XIENCE™ V Drug Eluting Stent receives

CE Mark of Approval 19

Biosensors Receives CE Mark Approval For BioMatrix® Stent System 19

Nfocus Neuromedical's CardioVasc™ Stent-Graft and Delivery

System Receives CE Mark Approval 19

InspireMD - MGuard™ Coronary Stent Launched in Italy 20

CeloNova BioSciences Launches CATANIA™ Coronary Stent with

Nano Thin Polyzene®-F 20

Angiotech Launches Cook Medical's Drug Eluting Zilver® PTX™

Stent in New Zealand 20

Cook Medical's Zilver Stent Receives Approval for Vascular Use

In Canada 21

Boston Scientific to Market TAXUS® EXPRESS2 Stent System in Japan 21

CE Mark Granted for the Use of Drug-eluting Stent, TAXUS®

Liberte™ in Diabetic Patients 21

Boston Scientific's TAXUS® Liberte™ Long Stent Receives CE

Mark Approval 21

Boston Scientific Launches Its Own Version of XIENCE™V Drug-

Eluting Coronary Stent in Europe 22

8. CLINICAL TRIALS AND KEY STUDIES 22

Canadian Study Indicates Superior Clinical Benefits of Drug-

Coated Stent 22

SPIRIT III Trial Confirms Superiority of Everolimus Eluting

Coronary Stent, XIENCE™ V Over TAXUS® Stent 22

Network Meta-Analysis Demonstrates Low Mortality Rates for

Both Drug-Eluting And Bare-Metal Stents 23

Study Proves Superiority of Cypher® Sirolimus-Eluting Coronary

Stent in Reduction of Blood Clot Risks and Reintervention

Compared to Taxus Stent 23

9. MAJOR PLAYERS 24

Angiotech Pharmaceuticals (Canada) 24

Boston Scientific Corp. (USA) 24

Cordis Corporation (JNJ) - (USA) 24

Cook Group, Inc. (USA) 25

Medtronic, Inc. (USA) 25

Medtronic Cardiovascular, Inc. (USA) 25

MIVI Technologies Inc. (Canada) 25

OrbusNeich (USA) 25

Sorin Biomedica Cardio (Italy) 26

Sun Biomedical Ltd. (USA) 26

10. MARKET ANALYTICS 27

11. THE UNITED STATES 33

Coronary Artery Disease - A US Perspective 33

Rapid Adoption of DES Technology in the US Market 33

Baby Boomers Boost Coronary Stent Market 33

Key Drivers of the US DES Market 34

Improved Treatment and Diagnosis 34

Long-Term Cost Reduction 34

Well-Organized Reimbursement System 34

Growing Patient Awareness 34

DES Technology - Economic Implications on the US Health Care

System 35

Soaring Costs of Multivessel Treatment - Still a Major Problem 35

Competitive Scenario 35

Leading Players 35

Coronary Stents - Boston Scientific and JNJ Battle for

Dominance 35

Regulatory Environment 37

12. JAPAN 39

Prospects Weighed down by Regulatory Entanglements 39

Japanese Government Steps in to Alleviate Pricing 39

Japanese Coronary Stents Command Higher Prices 39

Competitive Landscape 40

13. EUROPE 43

a. France 49

b. Germany 51

c. Italy 53

d. The United Kingdom 54

e. Spain 56

f. Russia 58

g. Rest of Europe 59

14. ASIA-PACIFIC 61

Coronary Stent Market in a Bubble Zone Now 61

Regional Players and their DES Development Efforts 61

Cost Focus Helps Stent Makers Win the Market Stunt 62

15. REST OF WORLD 63

Market Leaders 64

South Africa - Leading Players 64

EXHIBITS

Table 1: Growth in Angioplasty Procedures Vs Stent Penetration

Worldwide: (2006)

Table 2: Percentage Breakdown of Leading Coronary Stents

Manufacturer Revenues in the World - 2008

Table 3: Percentage Breakdown of Leading Bare Metal Stents

Manufacturer Revenues in the World - 2008

Table 4: Percentage Breakdown of Leading Drug-Eluting Stent

Manufacturer Revenues in the World - 2008

Table 5: Global Coronary Stents Market by Region for the

Period 2007-2015 (Sales in US$ Million)

Table 6: Percentage Breakdown (Dollar Sales) of Global

Coronary Stents Market by Region for the Years 2008 & 2012

Table 7: Global Coronary Stents Market by Region for the

Period 2007-2015 (Sales in Thousand Units)

Table 8: Percentage Breakdown (Unit Sales) of Global Coronary

Stents Market by Region for the Years 2008 & 2012

Table 9: Global Bare Metal Stents Market by Region for the

Period 2007-2015 (Sales in US$ Million)

Table 10: Percentage Breakdown (Dollar Sales) of Global Bare

Metal Stents Market by Region for the Years 2008 & 2012

Table 11: Global Bare Metal Stents Market by Region for the

Period 2007-2015 (Sales in Thousand Units)

Table 12: Percentage Breakdown (Unit Sales) of Global Bare

Metal Stents Market by Region for the Years 2008 & 2012

Table 13: Global Drug Eluting Stents Market by Region for the

Period 2007-2015 (Sales in US$ Million)

Table 14: Percentage Breakdown (Dollar Sales) of Global Drug

Eluting Stents Market by Region for the Years 2008 & 2012

Table 15: Global Drug Eluting Stents Market by Region for the

Period 2007-2015 (Sales in Thousand Units)

Table 16: Percentage Breakdown (Unit Sales) of Global Drug

Eluting Stents Market by Region for the Years 2008 & 2012

Table 17: Percentage Breakdown of Leading Coronary Stents

Manufacturer Revenues in the US - 2006

Table 18: Percentage Breakdown of Leading Bare Metal Stents

Manufacturer Revenues in the US - 2006

Table 19: Percentage Breakdown of Leading Drug-Eluting Stents

Manufacturer Revenues in the US - 2008

Table 20: Coronary Stents Market by Segment in the US:

2007-2015 (Sales in US$ Million)

Table 21: Percentage Breakdown (Dollar Sales) of Coronary

Stents Market by Segment in the US for the Years 2008 & 2012

Table 22: Coronary Stents Market by Segment in the US:

2007-2015 (Sales in Thousand Units)

Table 23: Percentage Breakdown (Unit Sales) of Coronary Stents

Market by Segment in the US for the Years 2008 & 2012

Table 24: Comparative Analysis of Coronary Stent Prices - 2008

Table 25: Percentage Breakdown of Leading Coronary Stent

Manufacturer Value Sales in Japan - 2006

Table 26: Percentage Breakdown of Leading Bare Metal Stent

Manufacturer Value Sales in Japan - 2006

Table 27: Percentage Breakdown of Leading Drug-Eluting Stent

Manufacturer Value Sales in Japan - 2008

Table 28: Coronary Stents Market by Segment in Japan:

2007-2015 (Sales in US$ Million)

Table 29: Percentage Breakdown (Dollar Sales) of Coronary

Stents Market by Segment in Japan for the Years 2008 & 2012

Table 30: Coronary Stents Market by Segment in Japan:

2007-2015 (Sales in Thousand Units)

Table 31: Percentage Breakdown (Unit Sales) of Coronary Stents

Market by Segment in Japan for the Years 2008 & 2012

Table 32: Percentage Breakdown of Leading Bare Metal Stent

Manufacturer Value Sales in Europe - 2006

Table 33: Percentage Breakdown of Leading Drug-Eluting Stent

Manufacturer Value Sales in Europe - 2006

Table 34: Coronary Stents Market by Region in Europe:

2007-2015 (Sales in US$ Million)

Table 35: Percentage Breakdown (Dollar Sales) of Coronary

Stents Market by Region in Europe for the Years 2008 & 2012

Table 36: Coronary Stents Market by Region in Europe:

2007-2015 (Sales in Thousand Units)

Table 37: Percentage Breakdown (Unit Sales) of Coronary Stents

Market by Region in Europe for the Years 2008 & 2012

Table 38: Coronary Stents Market by Segment in Europe:

2007-2015 (Sales in US$ Million)

Table 39: Percentage Breakdown (Dollar Sales) of Coronary

Stents Market by Segment in Europe for the Years 2008 & 2012

Table 40: Coronary Stents Market by Segment in Europe:

2007-2015 (Sales in Thousand Units)

Table 41: Percentage Breakdown (Unit Sales) of Coronary Stents

Market by Segment in Europe for the Years 2008 & 2012

Table 42: Coronary Stents Market by Segment in France:

2007-2015 (Sales in US$ Million)

Table 43: Percentage Breakdown (Dollar Sales) of Coronary

Stents Market by Segment in France for the Years 2008 & 2012

Table 44: Coronary Stents Market by Segment in France:

2007-2015 (Sales in Thousand Units)

Table 45: Percentage Breakdown (Unit Sales) of Coronary Stents

Market by Segment in France for the Years 2008 & 2012

Table 46: Coronary Stents Market by Segment in Germany:

2007-2015 (Sales in US$ Million)

Table 47: Percentage Breakdown (Dollar Sales) of Coronary

Stents Market by Segment in Germany for the Years 2008 & 2012

Table 48: Coronary Stents Market by Segment in Germany:

2007-2015 (Sales in Thousand Units)

Table 49: Percentage Breakdown (Unit Sales) of Coronary Stents

Market by Segment in Germany for the Years 2008 & 2012

Table 50: Coronary Stents Market by Segment in Italy:

2007-2015 (Sales in US$ Million)

Table 51: Percentage Breakdown (Dollar Sales) of Coronary

Stents Market by Segment in Italy for the Years 2008 & 2012

Table 52: Coronary Stents Market by Segment in Italy:

2007-2015 (Sales in Thousand Units)

Table 53: Percentage Breakdown (Unit Sales) of Coronary Stents

Market by Segment in Italy for the Years 2008 & 2012

Table 54: Coronary Stents Market by Segment in the UK:

2007-2015 (Sales in US$ Million)

Table 55: Percentage Breakdown (Dollar Sales) of Coronary

Stents Market by Segment in the UK for the Years 2008 & 2012

Table 56: Coronary Stents Market by Segment in the UK:

2007-2015 (Sales in Thousand Units)

Table 57: Percentage Breakdown (Unit Sales) of Coronary Stents

Market by Segment in the UK for the Years 2008 & 2012

Table 58: Coronary Stents Market by Segment in Spain:

2007-2015 (Sales in US$ Million)

Table 59: Percentage Breakdown (Dollar Sales) of Coronary

Stents Market by Segment in Spain for the Years 2008 & 2012

Table 60: Coronary Stents Market by Segment in Spain:

2007-2015 (Sales in Thousand Units)

Table 61: Percentage Breakdown (Unit Sales) of Coronary Stents

Market by Segment in Spain for the Years 2008 & 2012

Table 62: Coronary Stents Market by Segment in Russia:

2007-2015 (Sales in US$ Million)

Table 63: Percentage Breakdown (Dollar Sales) of Coronary

Stents Market by Segment in Russia for the Years 2008 & 2012

Table 64: Coronary Stents Market by Segment in Russia:

2007-2015 (Sales in Thousand Units)

Table 65: Percentage Breakdown (Unit Sales) of Coronary Stents

Market by Segment in Russia for the Years 2008 & 2012

Table 66: Coronary Stents Market by Segment in the Rest of

Europe: 2007-2015 (Sales in US$ Million)

Table 67: Percentage Breakdown (Dollar Sales) of Coronary

Stents Market by Segment in the Rest of Europe for the Years

2008 & 2012

Table 68: Coronary Stents Market by Segment in the Rest of

Europe: 2007- 2015 (Sales in Thousand Units)

Table 69: Percentage Breakdown (Unit Sales) of Coronary Stents

Market by Segment in the Rest of Europe for the Years 2008 &

2012

Table 70: Coronary Stents Market by Segment in Asia-Pacific:

2007-2015 (Sales in US$ Million)

Table 71: Percentage Breakdown (Dollar Sales) of Coronary

Stents Market by Segment in Asia-Pacific for the Years 2008 &

2012

Table 72: Coronary Stents Market by Segment in Asia-Pacific:

2007-2015 (Sales in Thousand Units)

Table 73: Percentage Breakdown (Unit Sales) of Coronary Stents

Market by Segment in Asia-Pacific for the Years 2008 & 2012

Table 74: Percentage Breakdown of Leading Coronary Stent

Manufacturer Value Sales in Rest of World - 2006

Table 75: Percentage Breakdown of Leading Coronary Stent

Manufacturer Unit Sales in Rest of World - 2006

Table 76: Coronary Stents Market by Segment in Rest of World:

2007-2015 (Sales in US$ Million)

Table 77: Percentage Breakdown (Dollar Sales) of Coronary

Stents Market by Segment in Rest of World for the Years 2008 &

2012

Table 78: Coronary Stents Market by Segment in Rest of World:

2007-2015 (Sales in Thousand Units)

Table 79: Percentage Breakdown (Unit Sales) of Coronary Stents

Market by Segment in Rest of World for the Years 2008 & 2012

COMPANIES PROFILED

To order this report:

Medical Equipment and Supply Industry: Coronary Stents - Global Market Trends

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Contact

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626


SOURCE Reportlinker

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here
   
Financial Widgets

Display market data, financial news or stock quotes - Learn More

Advertising Network

Advertise on FinancialContent's huge network - Learn More

Web Services

Power your internet and wireless applications - Learn More